Header Logo

Connection

Mark Pollack to Aged

Back to Details
This is a "connection" page, showing publications Mark Pollack has written about Aged.
Mark Pollack
Connection Strength
0.671
Aged
  1. Safety of resuming anti-PD-1 in patients with immune-related adverse events (irAEs) during combined anti-CTLA-4 and anti-PD1 in metastatic melanoma. Ann Oncol. 2018 01 01; 29(1):250-255.
    View in: PubMed
    Score: 0.058
  2. Cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected injection drug users: a randomized controlled trial. J Consult Clin Psychol. 2012 Jun; 80(3):404-15.
    View in: PubMed
    Score: 0.039
  3. A double-blind, placebo-controlled study of aripiprazole adjunctive to antidepressant therapy among depressed outpatients with inadequate response to prior antidepressant therapy (ADAPT-A Study). Psychother Psychosom. 2012; 81(2):87-97.
    View in: PubMed
    Score: 0.039
  4. Open-label support for duloxetine for the treatment of panic disorder. CNS Neurosci Ther. 2009; 15(1):19-23.
    View in: PubMed
    Score: 0.031
  5. High-field MRS study of GABA, glutamate and glutamine in social anxiety disorder: response to treatment with levetiracetam. Prog Neuropsychopharmacol Biol Psychiatry. 2008 Apr 01; 32(3):739-43.
    View in: PubMed
    Score: 0.029
  6. Levetiracetam as adjunctive therapy for refractory anxiety disorders. J Clin Psychiatry. 2007 Jul; 68(7):1010-3.
    View in: PubMed
    Score: 0.028
  7. Orthostatic panic as a key Vietnamese reaction to traumatic events: the case of September 11, 2001. Med Anthropol Q. 2007 Mar; 21(1):81-107.
    View in: PubMed
    Score: 0.028
  8. The selective GABA reuptake inhibitor tiagabine for the treatment of generalized anxiety disorder: results of a placebo-controlled study. J Clin Psychiatry. 2005 Nov; 66(11):1401-8.
    View in: PubMed
    Score: 0.025
  9. Fluoxetine for vestibular dysfunction and anxiety: a prospective pilot study. Psychosomatics. 2005 Jul-Aug; 46(4):334-9.
    View in: PubMed
    Score: 0.025
  10. Combined paroxetine and clonazepam treatment strategies compared to paroxetine monotherapy for panic disorder. J Psychopharmacol. 2003 Sep; 17(3):276-82.
    View in: PubMed
    Score: 0.022
  11. Predicting panic disorder among patients with chest pain: an analysis of the literature. Psychosomatics. 2003 May-Jun; 44(3):222-36.
    View in: PubMed
    Score: 0.021
  12. Paroxetine in the treatment of generalized anxiety disorder: results of a placebo-controlled, flexible-dosage trial. J Clin Psychiatry. 2001 May; 62(5):350-7.
    View in: PubMed
    Score: 0.018
  13. The Substance Use Intervention Team: A Preliminary Analysis of a Population-level Strategy to Address the Opioid Crisis at an Academic Health Center. J Addict Med. 2019 Nov/Dec; 13(6):460-463.
    View in: PubMed
    Score: 0.017
  14. Changes in Dosing and Dose Timing of D-Cycloserine Explain Its Apparent Declining Efficacy for Augmenting Exposure Therapy for Anxiety-related Disorders: An Individual Participant-data Meta-analysis. J Anxiety Disord. 2019 12; 68:102149.
    View in: PubMed
    Score: 0.016
  15. Evaluating patterns and predictors of symptom change during a three-week intensive outpatient treatment for veterans with PTSD. BMC Psychiatry. 2018 07 27; 18(1):242.
    View in: PubMed
    Score: 0.015
  16. Anxiety sensitivity moderates drug cravings in response to induced negative affect in opioid dependent outpatients. Addict Behav. 2018 09; 84:75-78.
    View in: PubMed
    Score: 0.015
  17. Negative Posttrauma Cognitions Mediate the Association Between Morally Injurious Events and Trauma-Related Psychopathology in Treatment-Seeking Veterans. J Trauma Stress. 2017 12; 30(6):698-703.
    View in: PubMed
    Score: 0.014
  18. Characteristics of veterans and military service members who endorse causing harm, injury, or death to others in the military. Psychol Trauma. 2018 May; 10(3):352-359.
    View in: PubMed
    Score: 0.014
  19. Effects of mindfulness meditation on occupational functioning and health care utilization in individuals with anxiety. J Psychosom Res. 2017 04; 95:7-11.
    View in: PubMed
    Score: 0.014
  20. A Pilot Study of Tailored Cognitive-Behavioral Resilience Training for Trauma Survivors With Subthreshold Distress. J Trauma Stress. 2016 06; 29(3):268-72.
    View in: PubMed
    Score: 0.013
  21. ADULT ANXIETY DISORDERS IN RELATION TO TRAIT ANXIETY AND PERCEIVED STRESS IN CHILDHOOD. Psychol Rep. 2015 Oct; 117(2):473-89.
    View in: PubMed
    Score: 0.012
  22. Anxiety psychopathology predictive of outcome in patients with panic disorder and depression treated with imipramine, alprazolam and placebo. J Affect Disord. 1994 Apr; 30(4):273-81.
    View in: PubMed
    Score: 0.011
  23. Augmentation of exposure therapy with post-session administration of D-cycloserine. J Psychiatr Res. 2013 Feb; 47(2):168-74.
    View in: PubMed
    Score: 0.010
  24. Understanding the relationship of perceived social support to post-trauma cognitions and posttraumatic stress disorder. J Anxiety Disord. 2011 Dec; 25(8):1072-8.
    View in: PubMed
    Score: 0.009
  25. Effect of acute posttrauma propranolol on PTSD outcome and physiological responses during script-driven imagery. CNS Neurosci Ther. 2012 Jan; 18(1):21-7.
    View in: PubMed
    Score: 0.009
  26. Anger, PTSD, and the nuclear family: a study of Cambodian refugees. Soc Sci Med. 2009 Nov; 69(9):1387-94.
    View in: PubMed
    Score: 0.008
  27. Efficacy and tolerability of duloxetine in elderly patients with generalized anxiety disorder: a pooled analysis of four randomized, double-blind, placebo-controlled studies. Hum Psychopharmacol. 2008 Aug; 23(6):519-26.
    View in: PubMed
    Score: 0.008
  28. Examination of the decline in symptoms of anxiety and depression in generalized anxiety disorder: impact of anxiety sensitivity on response to pharmacotherapy. Depress Anxiety. 2008; 25(2):167-71.
    View in: PubMed
    Score: 0.007
  29. Panic attacks and risk of incident cardiovascular events among postmenopausal women in the Women's Health Initiative Observational Study. Arch Gen Psychiatry. 2007 Oct; 64(10):1153-60.
    View in: PubMed
    Score: 0.007
  30. Clonazepam in the treatment of panic disorder and agoraphobia. Psychopharmacol Bull. 1987; 23(1):141-4.
    View in: PubMed
    Score: 0.007
  31. Cross-cultural differences in somatic presentation in patients with generalized anxiety disorder. J Nerv Ment Dis. 2006 Dec; 194(12):962-6.
    View in: PubMed
    Score: 0.007
  32. Panic attacks, daily life ischemia, and chest pain in postmenopausal women. Psychosom Med. 2006 Nov-Dec; 68(6):824-32.
    View in: PubMed
    Score: 0.007
  33. Clonazepam in the treatment of panic disorder and agoraphobia: a one-year follow-up. J Clin Psychopharmacol. 1986 Oct; 6(5):302-4.
    View in: PubMed
    Score: 0.007
  34. Treatment-emergent incontinence with lithium. J Clin Psychiatry. 1985 Oct; 46(10):444-5.
    View in: PubMed
    Score: 0.006
  35. Propranolol and depression revisited: three cases and a review. J Nerv Ment Dis. 1985 Feb; 173(2):118-9.
    View in: PubMed
    Score: 0.006
  36. Efficacy of the novel anxiolytic pregabalin in social anxiety disorder: a placebo-controlled, multicenter study. J Clin Psychopharmacol. 2004 Apr; 24(2):141-9.
    View in: PubMed
    Score: 0.006
  37. Prevalence and correlates of panic attacks in postmenopausal women: results from an ancillary study to the Women's Health Initiative. Arch Intern Med. 2003 Sep 22; 163(17):2041-50.
    View in: PubMed
    Score: 0.005
  38. Clinical significance of serum antibody responses to exotoxin A and type-specific lipopolysaccharides in patients with Pseudomonas aeruginosa infections. Am J Med. 1983 Jun; 74(6):980-7.
    View in: PubMed
    Score: 0.005
  39. Treatment of muscle contraction headache: Micrainin vs. aspirin. Headache. 1982 May; 22(3):101-9.
    View in: PubMed
    Score: 0.005
  40. Childhood history of anxiety disorders among adults with social phobia: rates, correlates, and comparisons with patients with panic disorder. Depress Anxiety. 2001; 14(4):209-13.
    View in: PubMed
    Score: 0.004
  41. Placebo-controlled study of gabapentin treatment of panic disorder. J Clin Psychopharmacol. 2000 Aug; 20(4):467-71.
    View in: PubMed
    Score: 0.004
  42. Efficacy of extended-release venlafaxine in nondepressed outpatients with generalized anxiety disorder. Am J Psychiatry. 2000 Jun; 157(6):968-74.
    View in: PubMed
    Score: 0.004
  43. Fluvoxamine treatment of social phobia (social anxiety disorder): a double-blind, placebo-controlled study. Am J Psychiatry. 1999 May; 156(5):756-60.
    View in: PubMed
    Score: 0.004
  44. Protective activity of antibodies to exotoxin A and lipopolysaccharide at the onset of Pseudomonas aeruginosa septicemia in man. J Clin Invest. 1979 Feb; 63(2):276-86.
    View in: PubMed
    Score: 0.004
  45. Prevalence and correlates of anger attacks: a two site study. J Affect Disord. 1996 Jun 20; 39(1):31-8.
    View in: PubMed
    Score: 0.003
  46. Predicting prospective episodes of depression in patients with panic disorder: a longitudinal study. J Consult Clin Psychol. 1994 Apr; 62(2):359-65.
    View in: PubMed
    Score: 0.003
  47. Influence of depression on the treatment of panic disorder with imipramine, alprazolam and placebo. J Affect Disord. 1993 May; 28(1):27-38.
    View in: PubMed
    Score: 0.003
  48. Cholera in Piura, Peru: a modern urban epidemic. J Infect Dis. 1992 Dec; 166(6):1429-33.
    View in: PubMed
    Score: 0.003
  49. Fluoxetine added to non-MAOI antidepressants converts nonresponders to responders: a preliminary report. J Clin Psychiatry. 1989 Dec; 50(12):447-9.
    View in: PubMed
    Score: 0.002
  50. Acute distress after switch from Norpramin to generic desipramine. Am J Psychiatry. 1989 Jan; 146(1):122.
    View in: PubMed
    Score: 0.002
  51. An open-label pilot study of oral S-adenosylmethionine in major depression. An interim report. Ala J Med Sci. 1988 Jul; 25(3):301-6.
    View in: PubMed
    Score: 0.002
  52. An open-label pilot study of oral S-adenosyl-L-methionine in major depression: interim results. Psychopharmacol Bull. 1988; 24(1):189-94.
    View in: PubMed
    Score: 0.002
  53. Clonazepam versus alprazolam in the treatment of panic disorder: interim analysis of data from a prospective, double-blind, placebo-controlled trial. J Clin Psychiatry. 1987 Oct; 48 Suppl:16-21.
    View in: PubMed
    Score: 0.002
  54. Orthostatic hypotension and antidepressant pharmacotherapy. Psychopharmacol Bull. 1987; 23(1):182-6.
    View in: PubMed
    Score: 0.002
  55. Enhancement of ECT benefit by yohimbine. J Clin Psychiatry. 1986 Oct; 47(10):508-10.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.